Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Neurologic manifestations of the antiphospholipid syndrome.

71 in total

1. Ocular involvement in primary antiphospholipid syndrome. Ocular involvement in primary APS.

Authors: F Y Demirci; R Küçükkaya; K Akarçay; N Kir; T Atamer; H Demirci; E Ongör
Journal: Int Ophthalmol Date: 1998 Impact factor: 2.031

2. Anticardiolipin antibodies are an independent risk factor for ischemic stroke.

Authors: J Zieliñska; D Ryglewicz; E Wierzchowska; W Lechowicz; D B Hier; A Czlonkowska
Journal: Neurol Res Date: 1999-10 Impact factor: 2.448

3. Role of anticardiolipin antibodies in young persons with migraine and transient focal neurologic events: a prospective study.

Authors: G E Tietjen; M Day; L Norris; S Aurora; A Halvorsen; L R Schultz; S R Levine
Journal: Neurology Date: 1998-05 Impact factor: 9.910

4. Recurrent acute transverse myelopathy associated with anticardiolipin antibodies.

Authors: A Campi; M Filippi; G Comi; G Scotti
Journal: AJNR Am J Neuroradiol Date: 1998-04 Impact factor: 3.825

5. High association of anticardiolipin antibodies with psychosis.

Authors: M Schwartz; M Rochas; B Weller; A Sheinkman; I Tal; D Golan; N Toubi; I Eldar; B Sharf; D Attias
Journal: J Clin Psychiatry Date: 1998-01 Impact factor: 4.384

6. Anticardiolipin antibodies and the risk of recurrent thrombo-occlusive events and death. The Antiphospholipid Antibodies and Stroke Study Group (APASS).

Authors:
Journal: Neurology Date: 1997-01 Impact factor: 9.910

7. Acute optic neuropathy and transverse myelopathy in patients with antiphospholipid antibody syndrome: favorable outcome after treatment with anticoagulants and glucocorticoids.

Authors: A Aziz; M D Conway; H J Robertson; L R Espinoza; W A Wilson
Journal: Lupus Date: 2000 Impact factor: 2.911

Neurologic manifestations of the antiphospholipid syndrome.

1. Ocular involvement in primary antiphospholipid syndrome. Ocular involvement in primary APS.

2. Anticardiolipin antibodies are an independent risk factor for ischemic stroke.

3. Role of anticardiolipin antibodies in young persons with migraine and transient focal neurologic events: a prospective study.

4. Recurrent acute transverse myelopathy associated with anticardiolipin antibodies.

5. High association of anticardiolipin antibodies with psychosis.

6. Anticardiolipin antibodies and the risk of recurrent thrombo-occlusive events and death. The Antiphospholipid Antibodies and Stroke Study Group (APASS).

7. Acute optic neuropathy and transverse myelopathy in patients with antiphospholipid antibody syndrome: favorable outcome after treatment with anticoagulants and glucocorticoids.

8. Association of antiphospholipid antibodies with central nervous system disease in systemic lupus erythematosus.

9. Pseudotumor syndrome associated with cerebral venous sinus occlusion and antiphospholipid antibodies.

10. Association between antiphospholipid antibodies and epilepsy in patients with systemic lupus erythematosus.

1. Chorea in primary antiphospholipid syndrome is associated with rheumatic fever.

2. Antibodies directed against ribosomal P proteins cross-react with phospholipids.

3. The pathogenesis of neural injury in animal models of the antiphospholipid syndrome.

4. Chorea and retinal vessel occlusion in a patient with systemic lupus erythematosus.

Review 5. Antiphospholipid Syndrome and the Neurologist: From Pathogenesis to Therapy.